Impact of ageing on the pharmacokinetics and pharmacodynamics of the drugs

No abstract is available for this paper.

• Publication year

  2022

• Venue

  Pharmacokinetics and Toxicokinetic Considerations

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/b978-0-323-98367-9.00008-1
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Kinetics of maternal–fetal drug transfer

  2021cited by this paper
• Biosimilars accessible in the market for the treatment of cancer.

  2021cited by this paper
• Bioanalytical method development and validation for establishing bioavailability and bioequivalence

  2021cited by this paper
• Biopharmaceutical considerations in the pediatric and geriatric formulation development

  2021cited by this paper
• “Organ-on-a-chip”-based physiologically relevant pharmacokinetic models

  2021cited by this paper
• Software used in ADME computation

  2021cited by this paper
• Implications for sex-related issues in clinical pharmacology and biopharmaceutics

  2021cited by this paper
• Influence of fever on pharmacokinetics of drugs

  2021cited by this paper
• Microdialysis: an emerging technique for pharmacokinetic–pharmacodynamic profiling

  2021cited by this paper
• Molecular mechanisms of circadian rhythm and its influence on the pharmacokinetics of drugs

  2021cited by this paper
• Revamping the pharmacokinetics of poorly soluble drugs using different formulations

  2021cited by this paper
• Drug metabolic kinetics

  2021cited by this paper
• Overview of biopharmaceutics and pharmacokinetics

  2021cited by this paper
• Pharmacokinetics modeling in drug delivery

  2021cited by this paper
• Pharmacogenomics and drug metabolism

  2021cited by this paper
• Pharmacokinetics aspects of biotechnological products

  2021cited by this paper
• Pharmacokinetics and biopharmaceutics: “a leader or attendant”

  2021cited by this paper
• Pharmacokinetics aspects of structural modifications in drug design and therapy

  2021cited by this paper
• New advances in insulin products

  2020cited by this paper
• Nanomedicines accessible in the market for clinical interventions.

  2020cited by this paper
• Endosomal escape tendency of drug delivery systems to mediate cytosolic delivery of therapeutics

  2020cited by this paper
• Hydrotropy, mixed hydrotropy, and mixed solvency as trending concept for solubilization of lipophilic drugs

  2020cited by this paper
• Recombinant blood products and therapeutic enzymes: An update

  2020cited by this paper
• Gene delivery to tackle diabetic nephropathy

  2020cited by this paper
• Resealed erythrocytes (RBCs) and their biomedical application

  2020cited by this paper
• Gold nanoparticles: An advanced drug delivery and diagnostic tool

  2020cited by this paper
• 3D printing as an emerging tool in pharmaceutical product development

  2020cited by this paper
• Recent advancements in solubilization of hydrophobic drugs

  2020cited by this paper
• Dendrimers as novel drug-delivery system and its applications

  2020cited by this paper
• Recent advances in regenerative medicine

  2020cited by this paper
• Development of Metronidazole Loaded Chitosan Nanoparticles Using QbD Approach—A Novel and Potential Antibacterial Formulation

  2020cited by this paper
• Cancer-targeted chemotherapy: Emerging role of the folate anchored dendrimer as drug delivery nanocarrier

  2020cited by this paper
• Self-microemulsifying drug-delivery system: ongoing challenges and future ahead

  2020cited by this paper
• Clinical pharmacology of old age

  2019cited by this paper
• Microemulsion as drug and gene delivery vehicle: an inside story

  2019cited by this paper
• Identifying Data Elements to Measure Frailty in a Dutch Nationwide Electronic Medical Record Database for Use in Postmarketing Safety Evaluation: An Exploratory Study

  2019cited by this paper
• Changing Epidemiology of the American Population.

  2019cited by this paper
• Antiepileptic drug therapy in the elderly: a clinical pharmacological review

  2019cited by this paper
• Computer-Aided Prediction of Pharmacokinetic (ADMET) Properties

  2018cited by this paper
• Review of antimicrobial use and considerations in the elderly population

  2018cited by this paper
• A randomized, double‐blind, placebo‐controlled crossover study of the effects of levetiracetam on cognition, mood, and balance in healthy older adults

  2017cited by this paper
• Clinical Outcomes Associated with Medication Regimen Complexity in Older People: A Systematic Review

  2017cited by this paper
• Pharmacokinetic and Pharmacodynamic Features of Nanoemulsion Following Oral, Intravenous, Topical and Nasal Route.

  2017cited by this paper
• Changes in Prescription and Over-the-Counter Medication and Dietary Supplement Use Among Older Adults in the United States, 2005 vs 2011.

  2016cited by this paper
• Antiepileptic drugs and hyponatremia in older adults: Two population‐based cohort studies

  2016cited by this paper
• Medications associated with geriatric syndromes and their prevalence in older hospitalized adults discharged to skilled nursing facilities.

  2016cited by this paper
• Sedative-hypnotics for sleepless geriatric patients: Choose wisly: Age-related physiologic changes, risk of adverse effects guide your prescribing

  2014cited by this paper
• Drug metabolism in older people--a key consideration in achieving optimal outcomes with medicines.

  2012cited by this paper
• Geriatric pharmacology and pharmacotherapy education for health professionals and students: a systematic review.

  2012cited by this paper
• Pharmacokinetics and pharmacodynamic changes associated with aging and implications for drug therapy.

  2012cited by this paper
• A systematic review of body fat distribution and mortality in older people.

  2012cited by this paper
• Age-related changes in pharmacodynamics: focus on drugs acting on central nervous and cardiovascular systems.

  2011cited by this paper
• Comparative effectiveness of 10 antiepileptic drugs in older adults with epilepsy.

  2010cited by this paper
• The aging heart: changes in the pharmacodynamic electrophysiological response to verapamil in aged rabbit hearts.

  2010cited by this paper
• Association of Community-Acquired Pneumonia With Antipsychotic Drug Use in Elderly Patients

  2010cited by this paper
• Blood-brain barrier: ageing and microvascular disease--systematic review and meta-analysis.

  2009cited by this paper
• Hospitalizations because of Adverse Drug Reactions in Elderly Patients Admitted through the Emergency Department

  2009cited by this paper
• Pharmacokinetics and drug metabolism in the elderly

  2009cited by this paper
• Use of antipsychotics in elderly patients with dementia: do atypical and conventional agents have a similar safety profile?

  2009cited by this paper
• Role of Angiotensin II Type 1 Receptor Antagonists in the Treatment of Hypertension in Patients Aged ≥65 Years

  2009cited by this paper
• Exploring dendrimer towards dual drug delivery: pH responsive simultaneous drug-release kinetics

  2009cited by this paper
• Sensitivity of older patients to antipsychotic motor side effects: a PET study examining potential mechanisms.

  2009cited by this paper
• Increased antipsychotic sensitivity in elderly patients: evidence and mechanisms.

  2009cited by this paper
• Effect of levetiracetam on depression and anxiety in adult epileptic patients.

  2008cited by this paper
• Pharmacodynamics in older adults: a review.

  2007cited by this paper
• Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review.

  2007cited by this paper
• The Role of Angiotensin II Type 1 Receptor Antagonists in Elderly Patients with Hypertension

  2006cited by this paper
• Hyponatremia Associated with Selective Serotonin-Reuptake Inhibitors in Older Adults

  2006cited by this paper
• Aging and Clinical Pharmacology: Implications for Antidepressants

  2005cited by this paper
• Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance.

  2005cited by this paper
• Tardive dyskinesia rates with atypical antipsychotics in older adults.

  2004cited by this paper
• Aging Biology and Geriatric Clinical Pharmacology

  2004cited by this paper
• The Aging Kidney: A Review – Part II

  2004cited by this paper
• Contents of The American Journal of Psychiatry

  2004cited by this paper
• Influence of liver disease and environmental factors on hepatic monooxygenase activity in vitro

  2004cited by this paper
• Postprandial Systolic Blood Pressure Responses of Older People in Residential Care: Association with Risk of Falling

  2003cited by this paper
• Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications.

  2003cited by this paper
• Generalizability of guidelines and physicians' adherence. Case study on the Sixth Joint National Commitee's guidelines on hypertension

  2003cited by this paper
• Susceptibility to neuroleptic-induced parkinsonism—age and increased substantia nigra echogenicity as putative risk factors

  2003cited by this paper
• When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly.

  2003cited by this paper
• Swallowing Disorders in the Elderly

  2002cited by this paper
• Changes in plasma protein binding have little clinical relevance

  2002cited by this paper
• Predicting Drug Absorption: How Nature Made It a Difficult Problem

  2002cited by this paper
• Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey.

  2002cited by this paper
• The Mucosa of the Small Intestine

  2002cited by this paper
• The influence of age on the pharmacokinetics and pharmacodynamics of bemetizide and triamterene: a single and multiple dose study.

  2001cited by this paper
• Anticholinergic effects of medication in elderly patients.

  2001cited by this paper
• Supplemental insurance and use of effective cardiovascular drugs among elderly medicare beneficiaries with coronary heart disease.

  2001cited by this paper
• Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study

  2001cited by this paper
• Mechanisms of photodamage of the skin and its functional consequences for skin ageing

  2001cited by this paper
• Age-Related Changes in Protein Binding of Drugs

  2000cited by this paper
• Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program.

  2000cited by this paper
• Fat and protein redistribution with aging: metabolic considerations

  2000cited by this paper
• Incidence and preventability of adverse drug events in nursing homes.

  2000cited by this paper
• Calcium-antagonist drugs.

  1999cited by this paper
• Incidence of selective serotonin reuptake inhibitor (SSRI) induced hyponatraemia due to the syndrome of inappropriate antidiuretic hormone (SIADH) secretion in the elderly

  1998cited by this paper
• Pharmacokinetic and Pharmacodynamic Changes in the Elderly

  1998cited by this paper
• Heat-related toxicity with the fentanyl transdermal patch.

  1998cited by this paper
• Chronopharmacokinetics

  1998cited by this paper
• The barrier function of CYP3A4 and P-glycoprotein in the small bowel.

  1997cited by this paper

• Use of Muscle Relaxants in Emergency Medicine: A Review

  2025cites this paper
• Use of Neuromuscular Blocking Agents in Elderly Patients: A Narrative Review in Geriatric Medicine

  2025cites this paper
• Association between polypharmacy and cognitive impairment in older adults: A systematic review and meta-analysis.

  2024cites this paper
• Deciphering the Intricate Interplay in the Framework of Antibiotic-Drug Interactions: A Narrative Review

  2024cites this paper